Skip to content

A Diagnostic Trial Study on the Accuracy of Acupoint Collection in the Digital Traditional Chinese Medicine Meridian Therapy System.

A Diagnostic Trial Study on the Accuracy of Acupoint Collection in the Digital Traditional Chinese Medicine Meridian Therapy System.

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ITMCTR
Registry ID
ITMCTR2026000350
Enrollment
Unknown
Registered
2026-02-11
Start date
2026-06-01
Completion date
Unknown
Last updated
2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy subjects

Interventions

Gold Standard:The acupoint localization by physicians of associate senior and above serves as a reference standard for evaluating the accuracy of machine-based acupoint localization. The acupoint loca
Index test:Digital Meridian Therapy System (Specification and Model: SY-3) Acupoint Location Accuracy Test

Sponsors

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Age: 18 -- 70 years old; 2) Height: 150 -- 190 centimeters; 3) Weight: Up to 100 kilograms; 4) Other: No external injuries, fully functional limbs and flexible joints, able to cooperate with specific poses during the test.

Exclusion criteria

Exclusion criteria: 1) Individuals with any prosthetic implants, including but not limited to spinal joint implants, breast implants, facial implants, etc.; 2) Subjects who have previously undergone corrective surgery for spinal, joint, or other areas; 3) Individuals suffering from diseases that may lead to physical deformities or functional disabilities, including but not limited to rheumatoid arthritis, ankylosing spondylitis, avascular necrosis of the femoral head, sequelae of poliomyelitis (polio), etc.; 4) Subjects with congenital malformations, incomplete limbs, or restricted limb mobility due to other causes; 5) Female subjects who are in a state of pregnancy or lactation; 6) Subjects with ulcers, significant scars on the skin of the study site, or contagious skin diseases (e.g., tinea corporis, impetigo, etc.); 7) Subjects deemed unsuitable for participation in this study by the investigator based on comprehensive assessment for other reasons.

Design outcomes

Primary

MeasureTime frame
Acupoint Recognition Accuracy;

Secondary

MeasureTime frame
Safety Index;

Countries

China

Contacts

Public ContactBin Li

Beijing Hospital of Traditional Chinese Medicine, Capital Medical University

libin@bjzhongyi.com18910781852

Outcome results

None listed

Source: ITMCTR (via WHO ICTRP) · Data processed: Jun 29, 2026